Cyphering the statistical and clinical significance of prasugrel in the TRITON-TIMI 38 trial.
Davide
D
Capodanno
Corrado
C
Tamburino
D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000453:epidemiology; D017326:Clinical Trials, Phase III as Topic; D003627:Data Interpretation, Statistical; D006801:Humans; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000453:epidemiology; D010879:Piperazines / Q000627:therapeutic use*; D000068799:Prasugrel Hydrochloride; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*; D012307:Risk Factors; D013876:Thiophenes / Q000627:therapeutic use*
D010879:Piperazines; D058921:Purinergic P2Y Receptor Antagonists; D013876:Thiophenes; D000068799:Prasugrel Hydrochloride